S&P 500

5.277,51

0,80%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Anthera Pharmaceuticals Inc (CE) (ANTH)
Anthera Pharmaceuticals Inc (CE) (ANTH) Notícias

ANTH

Anthera Pharmaceuticals (CE) (ANTH)

Anthera Pharmaceuticals Inc (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:ANTH

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
12/09/2018	16:21	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
30/07/2018	17:45	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
27/07/2018	07:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
20/07/2018	17:28	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
20/07/2018	17:28	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
20/07/2018	17:28	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
17/07/2018	15:38	Edgar (US Regulatory)	(25)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
09/07/2018	18:08	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
27/06/2018	09:00	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request and Suspension of Trading of its Securities on the...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
15/05/2018	17:00	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
12/03/2018	09:00	GlobeNewswire Inc.	Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
07/03/2018	10:30	GlobeNewswire Inc.	Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/03/2018	19:31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
06/03/2018	16:45	GlobeNewswire Inc.	Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
05/03/2018	19:32	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
05/03/2018	18:05	GlobeNewswire Inc.	Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
22/02/2018	18:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
08/02/2018	11:30	GlobeNewswire Inc.	Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Humphrey’s 4th Annual Orp...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
05/02/2018	11:30	GlobeNewswire Inc.	Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
25/01/2018	19:30	GlobeNewswire Inc.	Anthera Receives Positive Nasdaq Listing Determination	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
22/01/2018	11:30	GlobeNewswire Inc.	Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura: Stud...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
18/01/2018	20:29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
11/01/2018	18:07	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
09/01/2018	20:15	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
09/01/2018	09:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
08/01/2018	11:30	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
03/01/2018	11:30	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
11/12/2017	11:30	GlobeNewswire Inc.	Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollp...	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
04/12/2017	09:17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)
29/11/2017	19:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:ANTH	Anthera Pharmaceuticals Inc (CE)